Literature DB >> 2018477

Uptake and degradation of several pyrenesphingomyelins by skin fibroblasts from control subjects and patients with Niemann-Pick disease. Effect of the structure of the fluorescent fatty acyl residue.

T Levade1, S Gatt, R Salvayre.   

Abstract

Three fluorescent analogues of sphingomyelin (SPM), each containing pyrene in the fatty acyl residue, were synthesized and employed for the study of their mode of uptake by, and degradation within, intact cultured human skin fibroblasts. These were prepared by condensing sphingosylphosphocholine and the following fatty acids: pyrenedodecanoic acid (P12), pyrenesulphonylaminoundecanoic acid (PSA11) and pyrenepropenoic acid (P3:1). The cell association and catabolism of these SPM analogues by normal, Niemann-Pick-disease-Type-A and low-density-lipoprotein (LDL)-receptor-negative familial hypercholesterolaemia fibroblasts were investigated and compared with the metabolism of [cholinemethyl-14C]sphingomyelin. The catabolism of the fluorescent derivatives was monitored by measuring the appearance of the corresponding fluorescent ceramides. Two modes of uptake and degradation patterns were observed. Thus P12-SPM and radiolabelled SPM were taken up by LDL-receptor-mediated endocytosis when incubated with serum-containing medium, this conclusion being supported by the very low uptake by familial-hypercholesterolaemia fibroblasts, which lack the apolipoprotein-B/E receptor. After uptake, these compounds were metabolically degraded solely by the lysosomal sphingomyelinase, as evidenced by the fact that more than 98% of the SPM remained undegraded in Niemann-Pick-disease cells. By contrast, PSA11- and P3:1-SPMs were taken up by a receptor-independent endocytic pathway, as indicated by the similar rates of uptake in control and familial-hypercholesterolaemia cells in the absence or presence of fetal-calf serum in the culture medium. The degradation of PSA11-SPM and P3:1-SPM was brought about, in the main, by the lysosomal sphingomyelinase, but also by a yet uncharacterized process. The latter catabolic pathway, active in Niemann-Pick-disease-Type-A fibroblasts, seems to differ from the neutral Mg2(+)-dependent sphingomyelinase whose activity was undetectable in homogenates of skin fibroblasts. The present study emphasizes the influence of the structure of the fatty acyl moiety of SPM on its association with lipoproteins and/or cell membranes and on its intracellular routing and metabolic degradation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2018477      PMCID: PMC1150035          DOI: 10.1042/bj2750211

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  30 in total

1.  METHODS FOR METHANOLYSIS OF SPHINGOLIPIDS AND DIRECT DETERMINATION OF LONG-CHAIN BASES BY GAS CHROMATOGRAPHY.

Authors:  R C GAVER; C C SWEELEY
Journal:  J Am Oil Chem Soc       Date:  1965-04       Impact factor: 1.849

2.  A simple method for the isolation and purification of total lipides from animal tissues.

Authors:  J FOLCH; M LEES; G H SLOANE STANLEY
Journal:  J Biol Chem       Date:  1957-05       Impact factor: 5.157

3.  Neutral and acid sphingomyelinases: somatotopographical distribution in human brain and distribution in rat organs. A possible relationship with the dopamine system.

Authors:  M W Spence; J K Burgess; E R Sperker
Journal:  Brain Res       Date:  1979-06-08       Impact factor: 3.252

4.  Determination of protein: a modification of the Lowry method that gives a linear photometric response.

Authors:  E F Hartree
Journal:  Anal Biochem       Date:  1972-08       Impact factor: 3.365

5.  Lipoproteins of fetal and newborn calves and adult steer: a study of developmental changes.

Authors:  T M Forte; J J Bell-Quint; F Cheng
Journal:  Lipids       Date:  1981-04       Impact factor: 1.880

6.  Influence of chain length of pyrene fatty acids on their uptake and metabolism by Epstein-Barr-virus-transformed lymphoid cell lines from a patient with multisystemic lipid storage myopathy and from control subjects.

Authors:  J Radom; R Salvayre; T Levade; L Douste-Blazy
Journal:  Biochem J       Date:  1990-07-01       Impact factor: 3.857

7.  The role of sphingomyelin in phosphatidylcholine metabolism in cultured human fibroblasts from control and sphingomyelin lipidosis patients and in Chinese hamster ovary cells.

Authors:  M W Spence; H W Cook; D M Byers; F B Palmer
Journal:  Biochem J       Date:  1990-06-15       Impact factor: 3.857

8.  Studies in vitro on the biosynthesis of ceramide and sphingomyelin. A reevaluation of proposed pathways.

Authors:  W Stoffel; I Melzner
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1980-05

9.  Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia.

Authors:  J L Goldstein; M S Brown
Journal:  J Biol Chem       Date:  1974-08-25       Impact factor: 5.157

10.  Lipid recycling between the plasma membrane and intracellular compartments: transport and metabolism of fluorescent sphingomyelin analogues in cultured fibroblasts.

Authors:  M Koval; R E Pagano
Journal:  J Cell Biol       Date:  1989-06       Impact factor: 10.539

View more
  3 in total

Review 1.  Cholesterol regulation of rab-mediated sphingolipid endocytosis.

Authors:  Miwa Takahashi; Toshihide Kobayashi
Journal:  Glycoconj J       Date:  2008-10-08       Impact factor: 2.916

2.  Endocytic trafficking of sphingomyelin depends on its acyl chain length.

Authors:  Mirkka Koivusalo; Maurice Jansen; Pentti Somerharju; Elina Ikonen
Journal:  Mol Biol Cell       Date:  2007-10-17       Impact factor: 4.138

3.  Evidence against involvement of the acid lysosomal sphingomyelinase in the tumor-necrosis-factor- and interleukin-1-induced sphingomyelin cycle and cell proliferation in human fibroblasts.

Authors:  N Andrieu; R Salvayre; T Levade
Journal:  Biochem J       Date:  1994-10-15       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.